Literature DB >> 11500353

Airway smooth muscle cell proliferation is increased in asthma.

P R Johnson1, M Roth, M Tamm, M Hughes, Q Ge, G King, J K Burgess, J L Black.   

Abstract

UNLABELLED: Increased airway smooth muscle (ASM) within the bronchial wall of asthmatic patients has been well documented and is likely to be the result of increased muscle proliferation. We have for the first time been able to culture ASM cells from asthmatic patients and to compare their proliferation rate with that of nonasthmatic patients. Asthmatic ASM cell cultures (n = 12) were established from explanted lungs and endobronchial biopsies. Nonasthmatic ASM cells (n = 10) were obtained from explanted tissue from patients with no airway disease, emphysema, carcinoma, and fibrosing alveolitis. Cell counts, tritiated thymidine incorporation, and cell cycle analysis were conducted over 7 d. Asthmatic ASM cell numbers at Days 3, 5, and 7 were significantly higher than corresponding values for nonasthmatic cells (p < 0.05). Tritiated thymidine incorporation was increased 3.2-fold in asthmatic cells compared with nonasthmatic cells within the first 24 h (p = 0.026). Flow cytometric analysis of DNA content on Days 1 and 2 revealed that a significantly greater percentage of asthmatic ASM cells were in the G2 + M phase (p < 0.05). This study shows for the first time that proliferation of ASM cells is increased in patients with asthma and provides evidence for an intrinsic abnormality in the ASM cell in this disease. KEYWORDS: asthma; human airway smooth muscle; cell culture; cell proliferation; hyperplasia

Entities:  

Mesh:

Year:  2001        PMID: 11500353     DOI: 10.1164/ajrccm.164.3.2010109

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  138 in total

Review 1.  Airway smooth muscle and fibroblasts in the pathogenesis of asthma.

Authors:  Peter R A Johnson; Janette K Burgess
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

2.  Inhibition of airway remodeling in IL-5-deficient mice.

Authors:  Jae Youn Cho; Marina Miller; Kwang Je Baek; Ji Won Han; Jyothi Nayar; Sook Young Lee; Kirsti McElwain; Shauna McElwain; Stephanie Friedman; David H Broide
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

3.  Glucocorticoid-dependent phosphorylation of the transcriptional coregulator GRIP1.

Authors:  Jana Dobrovolna; Yurii Chinenov; Megan A Kennedy; Bill Liu; Inez Rogatsky
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

Review 4.  Point: alterations in airway smooth muscle phenotype do/do not cause airway hyperresponsiveness in asthma.

Authors:  Susan J Gunst; Reynold A Panettieri
Journal:  J Appl Physiol (1985)       Date:  2012-04-19

5.  Antimitogenic effect of bitter taste receptor agonists on airway smooth muscle cells.

Authors:  Pawan Sharma; Alfredo Panebra; Tonio Pera; Brian C Tiegs; Alena Hershfeld; Lawrence C Kenyon; Deepak A Deshpande
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-18       Impact factor: 5.464

6.  Regulator of G-protein signaling-5 inhibits bronchial smooth muscle contraction in severe asthma.

Authors:  Zhao Yang; Nariman Balenga; Philip R Cooper; Gautam Damera; Richard Edwards; Christopher E Brightling; Reynold A Panettieri; Kirk M Druey
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-26       Impact factor: 6.914

7.  Collagen impairs glucocorticoid actions in airway smooth muscle through integrin signalling.

Authors:  J V Bonacci; M Schuliga; T Harris; A G Stewart
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

Review 8.  Stem cells in airway smooth muscle: state of the art.

Authors:  Jaime Murphy; Ross Summer; Alan Fine
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

Review 9.  Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration.

Authors:  J Kelley Bentley; Marc B Hershenson
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

Review 10.  Biophysical basis for airway hyperresponsiveness.

Authors:  Steven S An; Jeffrey J Fredberg
Journal:  Can J Physiol Pharmacol       Date:  2007-07       Impact factor: 2.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.